"Improvements" (also: Improvement)
There are two definitions of "Improvements" used in the MAPGuide:
(1) All improvements, methods, modifications and other know-how developed by or on behalf of a Licensee and relating to a Product.
(2) Any and all improvements, enhancements or modifications, patentable or otherwise, relating to the Compound or Licensed Products or Licensed Combination Products including, without limitation, any change or modification in the manufacture, formulation, analytical methodology, ingredients, preparation, presentation or means of delivery, administration or dosage of the Compound or Licensed Products or Licensed Combination Products.
"Incentives" (also: Incentive)
Anything that encourages a party to do something or to work harder.
"Increased Outbreak Preparation Need"
There are three definitions of “Increased Outbreak Preparation Need” used in the MAPGuide:
(1) When, having considered all reasonably accessible and relevant information including epidemiological data, travel and migration patterns and the likely availability of other products or product candidates, there is a determination that there is a heightened need for a Product.
(2) When, having considered all reasonably accessible and relevant information including epidemiological data, travel and migration patterns and the likely availability of other products or product candidates in the Field, Funder determines, in its sole discretion, that there is a heightened need for the Product.
Also see the definitions of “Outbreak,” “Outbreak Notice,” “Outbreak Preparation Activities,” and “Outbreak Response Activities.”
Any communication or reception of knowledge or intelligence; knowledge obtained from investigation, study, or instruction: intelligence, news, facts, data.
(a) Having generally ceased to pay debts in the ordinary course of business other than as a result of bona fide dispute, (b) being unable to pay debts as they become due, or (c) being insolvent within the meaning of federal bankruptcy law.
"Intellectual Property" (also: IP)
There are four definitions of “Intellectual Property (IP)” used in the MAPGuide:
(1) All intellectual property rights arising from or associated with the following, whether created, protected or arising under the laws of the United Kingdom or any other jurisdiction:
(a) trade names, trademarks and service marks (whether registered or unregistered), domain names and other internet addresses or identifiers, trade dress and similar rights and applications to register any of the foregoing (collectively, “Marks”);
(b) patents and patent applications and rights in respect of utility models or industrial designs (collectively, “Patents”);
(c) copyrights (whether registered or unregistered) and registrations and applications therefor (collectively, “Copyrights”);
(d) know-how, inventions, discoveries, methods, processes, techniques, methodologies, formulae, algorithms, technical data, specifications, research and development information, technology, data bases and other proprietary or confidential information, including customer lists, in each case that derives economic value (actual or potential) from not being generally known to other persons who can obtain economic value from its disclosure, but excluding any Copyrights or Patents that cover or protect any of the foregoing (collectively, “Trade Secrets”); and
(e) any other proprietary, intellectual or industrial property rights of any kind or nature that do not comprise or are not protected by Marks, Patents, Copyrights or Trade Secrets.
(2) Any or all of the following and all rights in, arising out of, or associated therewith:
(a) all United States and foreign patents and utility models and applications therefor and all reissues, divisions, renewals, reexaminations, extensions, provisionals, continuations and continuations-in-part thereof, and equivalent or similar rights anywhere in the world in inventions, disclosures, and discoveries, whether or not patentable, and whether or not reduced to practice (“Patents”);
(b) all trade secrets, know-how, proprietary information, technical data, improvements, technology, computer programs (in source code and executable code form, and whether embodied in software, firmware or otherwise), documentation (including software documentation), drawings, designs, flow charts, specifications, logic diagrams, programmer notes, protocols, files, records, databases, formulae, compositions, processes, manufacturing and production processes and techniques, research and development information, improvements, proposals, and technical data (“Technical Information”);
(c) all copyrights, works of authorship, copyright registrations and applications therefor and all other rights corresponding thereto throughout the world (“Copyrights”);
(d) all industrial designs and any registrations and applications therefor throughout the world;
(e) any similar, corresponding or equivalent rights to any of the foregoing anywhere in the world, including but not limited to computer program rights and registrations and applications therefor; and
(f) all copies and tangible embodiments of the foregoing (in whatever form or media).
(3) All rights in Copyrights, Patents, Mask Works, Trademarks, Technology and any other proprietary rights relating to intangible property anywhere in the world, and all registrations and applications related to any of the foregoing and analogous rights thereto anywhere in the world.
(4) Means any worldwide intellectual property or other proprietary rights (excluding trademark, service mark, and domain name rights), including but not limited to copyrights, trade dress rights (including audible characteristics), mask work rights registrations, moral rights, patent rights, patent applications and disclosures, know-how, inventions, rights of priority, and trade secret rights.
"Interchangeable Pharmaceutical Products" (also: Interchangeable Pharmaceutical Product)
Products within a therapeutic class, but with different active ingredients are interchangeable if they have equivalent therapeutic effect.
"International Nonproprietary Name" (also: INN)
A common, generic name selected by designated experts for the unambiguous identification of a new pharmaceutical substance. The selection process is based on a procedure and guiding principles adopted by the World Health Assembly. INNs are recommended for worldwide use.
"International Standard" (also: International Standards)
A biological standard accepted by WHO for use as an International Reference Preparation.
"Investigational Product" (also: Investigational Products)
A Product that has not received a marketing approval.